Prevalence of Neutralizing Factors Against Adeno-Associated Virus Types 2 in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|13|3|182-188

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.13, Iss.3, 2013-06, pp. : 182-188

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety of verteporfin for treatment of subfoveal choroidal neovascular membranes associated with age-related macular degeneration

By Gaynes Bruce I Fiscella Richard G

Expert Opinion on Drug Safety, Vol. 3, Iss. 4, 2004-07 ,pp. : 345-361

Informa Healthcare

Access to resources Recommend Favorite

The Burden of Age-Related Macular Degeneration

By Schmier Jordana K. Jones Mechelle L. Halpern Michael T.

PharmacoEconomics, Vol. 24, Iss. 4, 2006-01 ,pp. : 319-334

Adis International

Access to resources Recommend Favorite

Restriction Factors Against Recombinant Adeno-associated Virus Vectormediated Gene Transfer in Dystrophin-deficient Muscles

Current Gene Therapy, Vol. 16, Iss. 3, 2016-06 ,pp. : 168-183

Bentham Science Publishers

Access to resources Recommend Favorite

Pegaptanib: In Exudative Age-Related Macular Degeneration

By Siddiqui M. Asif A. Keating Gillian M.

Drugs, Vol. 65, Iss. 11, 2005-01 ,pp. : 1571-1577

Adis International

Access to resources Recommend Favorite

By Lacour M.

Drugs & Aging, Vol. 19, Iss. 2, 2002-02 ,pp. : 101-133

Adis International

Access to resources Recommend Favorite